Marksans Pharma Ltd. - Research Center
524404 MARKSANS Group (A) BSE data
Results
|
Half yearly
|
Statement
|
|
More
|
|
Half yearly results in brief
(Rs crore)
|
Sep ' 23 |
Sep ' 22 |
Mar ' 22 |
Sep ' 21 |
Sep ' 20 |
Sales |
386.71 |
329.41 |
342.22 |
316.07 |
293.51 |
Operating profit |
64.06 |
45.38 |
54.69 |
59.03 |
52.05 |
Interest |
0.49 |
2.11 |
1.96 |
1.83 |
2.11 |
Gross profit |
112.12 |
83.74 |
72.44 |
79.73 |
62.95 |
EPS (Rs) |
1.67 |
1.47 |
1.16 |
1.38 |
1.11 |
Half yearly
results in details
|
Sep ' 23 |
Sep ' 22 |
Mar ' 22 |
Sep ' 21 |
Sep ' 20 |
Other income |
48.55 |
40.47 |
19.71 |
22.54 |
13.01 |
Stock adjustment |
-3.65 |
-3.91 |
3.40 |
0.49 |
0.07 |
Raw material |
185.62 |
170.25 |
163.64 |
164.35 |
137.29 |
Power and fuel |
- |
- |
- |
- |
- |
Employee expenses |
35.16 |
26.87 |
30.50 |
29.96 |
25.13 |
Excise |
- |
- |
- |
- |
- |
Admin and selling expenses |
- |
- |
- |
- |
- |
Research and development expenses |
- |
- |
- |
- |
- |
Expenses capitalised |
- |
- |
- |
- |
- |
Other expenses |
105.53 |
90.82 |
89.99 |
62.24 |
78.97 |
Provisions made |
- |
- |
- |
- |
- |
Depreciation |
13.22 |
9.05 |
9.13 |
8.53 |
7.01 |
Taxation |
23.42 |
15.25 |
15.82 |
14.70 |
10.34 |
Net profit / loss |
75.48 |
59.44 |
47.48 |
56.50 |
45.59 |
Extra ordinary item |
- |
- |
- |
- |
- |
Prior year adjustments |
- |
- |
- |
- |
- |
Equity capital |
45.32 |
40.42 |
40.93 |
40.93 |
40.93 |
Equity dividend rate |
- |
- |
- |
- |
- |
Agg.of non-prom. shares (Lacs) |
- |
- |
- |
- |
- |
Agg.of non promotoholding (%) |
- |
- |
- |
- |
- |
OPM (%) |
16.56 |
13.78 |
15.98 |
18.68 |
17.73 |
GPM (%) |
25.76 |
22.64 |
20.01 |
23.55 |
20.54 |
NPM (%) |
17.34 |
16.07 |
13.12 |
16.69 |
14.87 |